Yubo International Biotech Limited
YBGJ
$0.01
$0.005.26%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -261.40K | -276.80K | -105.40K | -435.60K | -289.70K |
| Total Depreciation and Amortization | 44.40K | 43.60K | 45.10K | 44.60K | 42.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -24.20K | -84.50K | 31.70K | -31.70K | -67.60K |
| Change in Net Operating Assets | 112.50K | -41.40K | 65.60K | 30.70K | -617.80K |
| Cash from Operations | -128.80K | -359.10K | 37.10K | -392.00K | -932.70K |
| Capital Expenditure | -- | -- | 6.20K | -6.20K | -- |
| Sale of Property, Plant, and Equipment | -79.90K | 0.00 | 79.90K | -- | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -79.90K | 0.00 | 86.10K | -6.20K | 0.00 |
| Total Debt Issued | 375.60K | 0.00 | 196.10K | 277.80K | 1.03M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 76.80K |
| Cash from Financing | 375.60K | 0.00 | 196.10K | 277.80K | 1.11M |
| Foreign Exchange rate Adjustments | -169.80K | 359.60K | -318.60K | 123.20K | -177.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.90K | 500.00 | 600.00 | 2.80K | -1.00K |